COVID-19: ‘We might not be in a great spot in the fall’: Moderna CEO

Financial

The majority of Moderna’s (MNRA) revenue comes from governments abroad — which are bracing are for an ongoing need for COVID-19 vaccines this year. While the U.S. waits on funding and for the U.S. Food and Drug Administration (FDA) to decide on which virus strain to attack through boosters, Moderna and other vaccine companies are…

Thanks for reading The LBM Daily.
Join LBM Daily Premium or log in to continue reading.
Login Join Now

Articles You May Like

RI Senate leaders save tax break for solar developers with last-minute maneuvering
Winners announced for $2M Mass Timber Competition: Building to Net-Zero Carbon
Russia appears to miss its foreign debt payments deadline, falling into default.
Lumber suppliers cut prices to increase sales
Pacific Woodtech acquires LP’s EWP business for $210M